marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Lumos Pharma Balance Sheet 2011-2024 | LUMO
Annual Balance Sheet Lumos Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-94.3 M | -98.4 M | -3.85 M | -121 M | -158 M | -131 M | -195 M | 1.1 M | 454 K | 449 K | 393 K | ||
Long Term Debt |
303 K | - | 205 K | - | - | 43 K | 111 K | 285 K | 368 K | 941 K | 300 K | 300 K | 300 K |
Long Term Debt Current |
282 K | 233 K | 352 K | 319 K | 1.1 M | - | - | - | 558 K | 157 K | 154 K | 149 K | 93 K |
Total Non Current Liabilities |
- | - | 6.2 M | - | 191 K | 6.95 M | 7.11 M | 7.38 M | 7.93 M | 9.26 M | 8.35 M | 8.58 M | 942 K |
Total Current Liabilities |
7.03 M | 6.71 M | 5.13 M | 6.46 M | 11.8 M | 8.85 M | 22 M | 37.9 M | 14.8 M | 25 M | 3.88 M | 2.92 M | 10.7 M |
Total Liabilities |
13.3 M | 12.7 M | 11.3 M | 12.5 M | 1.45 M | 15.8 M | 29.1 M | 45.3 M | 22.8 M | 34.3 M | 12.2 M | 11.5 M | 11.6 M |
Deferred Revenue |
- | - | - | - | - | - | 56 K | 391 K | 892 K | 13 M | - | - | - |
Retained Earnings |
-162 M | -127 M | -96.4 M | -66 M | -59.7 M | -291 M | -237 M | -166 M | -80.4 M | -33.1 M | 58.3 M | 17.9 M | 36.8 M |
Total Assets |
40.6 M | 72.3 M | 100 M | 129 M | 5.53 M | 131 M | 181 M | 175 M | 219 M | 238 M | 70.6 M | 29.4 M | 48.4 M |
Cash and Cash Equivalents |
35.1 M | 56 M | 94.8 M | 98.7 M | 90.5 M | 121 M | 159 M | 131 M | 196 M | 190 M | 61.3 M | 20.2 M | 39.5 M |
Book Value |
27.3 M | 59.6 M | 89 M | 117 M | 4.07 M | 115 M | 152 M | 129 M | 196 M | 204 M | 58.3 M | 17.9 M | 36.8 M |
Total Shareholders Equity |
27.3 M | 59.6 M | 89 M | 117 M | -59.5 M | 115 M | 152 M | 129 M | 196 M | 204 M | 58.3 M | 17.9 M | 36.8 M |
All numbers in USD currency
Quarterly Balance Sheet Lumos Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
42 K | 145 K | 225 K | 303 K | 143 K | 167 K | 189 K | - | 19 K | 75 K | 131 K | 205 K | 288 K | 370 K | 106 K | - | - | - | - | - | - | 11 K | 27 K | 43 K | 43 K | 43 K | 43 K | 111 K | 111 K | 111 K | 111 K | 285 K | 285 K | 285 K | 453 K | 368 K | 409 K | 450 K | 494 K | 941 K | 989 K | 941 K | 941 K | 1.03 M | 1.08 M | 1.03 M | 1.03 M | 1.18 M | - | 1.18 M | 1.18 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 6.19 M | 6 M | 6.02 M | 6.08 M | 6.13 M | 6.2 M | 6.29 M | 6.37 M | 6.11 M | 6 M | 6 M | 6 M | 6 M | 191 K | 191 K | 191 K | 191 K | 6.95 M | 6.95 M | 6.95 M | 6.95 M | 7.11 M | 7.11 M | 7.11 M | 7.11 M | 7.38 M | 7.38 M | 7.38 M | 7.38 M | 7.93 M | 7.93 M | 7.93 M | 7.93 M | 9.26 M | 9.26 M | 9.26 M | 9.26 M | 8.35 M | 8.35 M | 8.35 M | 8.35 M | 8.58 M | 8.58 M | 8.58 M | 8.58 M | 942 K | 942 K | 942 K | 942 K |
Total Liabilities |
12.5 M | 11.1 M | 10.6 M | 13.3 M | 12.3 M | 12.7 M | 11.2 M | 12.7 M | 11.5 M | 10.9 M | 11.4 M | 11.3 M | 12.3 M | 13.1 M | 11.1 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 45.3 M | 45.3 M | 45.3 M | 45.3 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 56 K | 56 K | 56 K | 56 K | 391 K | 391 K | 391 K | 391 K | 892 K | 892 K | 892 K | 892 K | 13 M | 13 M | 13 M | 13 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-187 M | -180 M | -172 M | -162 M | -152 M | -144 M | -135 M | -127 M | -119 M | -112 M | -104 M | -96.4 M | -90.8 M | -83.3 M | -74.6 M | -66 M | -66 M | -66 M | -66 M | -59.7 M | -59.7 M | -59.7 M | -59.7 M | -291 M | -291 M | -291 M | -291 M | -237 M | -237 M | -237 M | -237 M | -166 M | -166 M | -166 M | -166 M | -80.4 M | -80.4 M | -80.4 M | -80.4 M | -40 M | -40 M | -33.1 M | -33.1 M | -136 M | -136 M | -136 M | - | - | - | - | - | - | - | - | - |
Total Assets |
17.5 M | 21.4 M | 28.1 M | 40.6 M | 47.8 M | 56.4 M | 63.7 M | 72.3 M | 79.2 M | 85.5 M | 93.2 M | 100 M | 106 M | 114 M | 120 M | 129 M | 129 M | 129 M | 129 M | 5.53 M | 5.53 M | 5.53 M | 5.53 M | 131 M | 131 M | 131 M | 131 M | 181 M | 181 M | 181 M | 181 M | 175 M | 175 M | 175 M | 175 M | 219 M | 219 M | 219 M | 219 M | 231 M | 231 M | 238 M | 238 M | 70.6 M | 70.6 M | 70.6 M | 70.6 M | 29.4 M | 29.4 M | 29.4 M | 29.4 M | 48.4 M | 48.4 M | 48.4 M | 48.4 M |
Cash and Cash Equivalents |
13.5 M | 16.8 M | 23.2 M | 35.1 M | 35.6 M | 37.9 M | 44 M | 56 M | 73.7 M | 79.5 M | 86.8 M | 94.8 M | 101 M | 108 M | 114 M | 98.7 M | 98.7 M | 98.7 M | 98.7 M | 4.95 M | 4.95 M | 4.95 M | 4.95 M | 121 M | 121 M | 121 M | 121 M | 159 M | 159 M | 159 M | 159 M | 131 M | 131 M | 131 M | 131 M | 196 M | 196 M | 196 M | 196 M | 190 M | 190 M | 190 M | 190 M | 61.3 M | 61.3 M | 61.3 M | 61.3 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 39.5 M | 39.5 M | 39.5 M | 39.5 M |
Book Value |
4.91 M | 10.3 M | 17.4 M | 27.3 M | 35.5 M | 43.7 M | 52.5 M | 59.6 M | 67.7 M | 74.5 M | 81.8 M | 89 M | 94.1 M | 101 M | 109 M | 117 M | 117 M | 117 M | 117 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 115 M | 115 M | 115 M | 115 M | 152 M | 152 M | 152 M | 152 M | 129 M | 129 M | 129 M | 129 M | 196 M | 196 M | 196 M | 196 M | 197 M | 197 M | 204 M | 204 M | 58.3 M | 58.3 M | 58.3 M | 58.3 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M |
Total Shareholders Equity |
4.91 M | 10.3 M | 17.4 M | 27.3 M | 35.5 M | 43.7 M | 52.5 M | 59.6 M | 67.7 M | 74.5 M | 81.8 M | 89 M | 94.1 M | 101 M | 109 M | 117 M | 117 M | 117 M | 117 M | -59.5 M | -59.5 M | -59.5 M | -59.5 M | -46.9 M | 115 M | 115 M | 115 M | 152 M | 152 M | 152 M | 152 M | 129 M | 129 M | 129 M | 177 M | 196 M | 196 M | 196 M | 196 M | 197 M | 197 M | 204 M | 204 M | 58.3 M | 58.3 M | 58.3 M | 58.3 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 36.8 M | -71.4 M | 36.8 M | 36.8 M |
All numbers in USD currency